CRA_9076

CRA_9076 is an experimental small molecule belonging to the class of organic compounds known as 2‑phenylindoles. Its structure features an indole core with a brominated and methylated phenol moiety, and a carboxamidine group. It has been studied primarily as a serine protease inhibitor, specifically targeting urokinase-type plasminogen activator (uPA), which is involved in processes such as extracellular matrix degradation and tumor metastasis. The compound has not been approved for any indication and remains at the experimental stage[1][2][4]. Its molecular formula is C16H14BrN3O, with a molecular weight of approximately 344.21 g/mol[2].

Other names

2-{5-[AMINO(IMINIO)METHYL]-1H-indol-2-YL}-6-bromo-4-methylbenzenolate2-(3-Bromo-2-hydroxy-5-methylphenyl)-1H-indole-5-carboxamidine